Study of NG-641 in Combination With Nivolumab in Metastatic or Advanced Epithelial Tumours

NCT05043714 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Cancer
Epithelial Tumor

Interventions

BIOLOGICAL: NG-641 in combination with Nivolumab

Sponsor

Akamis Bio

Collaborators

[object Object]